Pierre Fabre clinical trials

Part of Pierre Fabre Participations. Source

The registry lists 145 studies whose lead sponsor is Pierre Fabre or one of 6 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 145. Browse all 145 →

• A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyRecruitingNCT03394365Phase 3

  Sponsor listed in the registry: Pierre Fabre Medicament

• First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion MutationsRecruitingNCT06043817Phase 1/2

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsRecruitingNCT04913285Phase 1

  Sponsor listed in the registry: Pierre Fabre Medicament

• Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIsRecruitingNCT06567015Phase 1/2

  Sponsor listed in the registry: Pierre Fabre Medicament

• Comparison Between Different Interdental Brushes in Adults With Periodontal Disease.RecruitingNCT07575997Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksRecruitingNCT07014007Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET AlterationsRecruitingNCT06669117Phase 1/2

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance PhaseRecruitingNCT06716398Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC TreatmentRecruitingNCT04673955

  Sponsor listed in the registry: Pierre Fabre Pharma GmbH

• Treatment Patterns of Neratinib in HER2+ EBC in ChinaNot yet recruitingNCT05491057

  Sponsor listed in the registry: Pierre Fabre Medicament

• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma TreatmentRecruitingNCT04045691

  Sponsor listed in the registry: Pierre Fabre Pharma GmbH

• Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International StudyCompletedNCT07096206

  Sponsor listed in the registry: Pierre Fabre Medicament

• EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLORCompletedNCT07839897Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITISCompletedNCT07819071Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Study on Structum® in Adult Patients With Osteoarthritis (TRUST)CompletedNCT06623773

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesActive, not recruitingNCT04554914Phase 2

  Sponsor listed in the registry: Pierre Fabre Medicament

• Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerCompletedNCT03693170Phase 2

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Randomized, Comparative Study to Evaluate the Effect of RL3014A-DP0421 Mouthwash on the Oral Microbial CompositionCompletedNCT07685782Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of TreatmentActive, not recruitingNCT06500494

  Sponsor listed in the registry: Pierre Fabre Medicament

• Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic TreatmentsCompletedNCT07577921

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.TerminatedNCT06446063

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisCompletedNCT07576023Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and PruritusCompletedNCT06800755Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding EmollientsCompletedNCT06983561

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin PhototypeCompletedNCT07166484

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT05195632Phase 2

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.CompletedNCT05004350Phase 2

  Sponsor listed in the registry: Pierre Fabre Medicament

• UK ENcorafenib and BInimetinib Real-world Study in MelanomaActive, not recruitingNCT07022457

  Sponsor listed in the registry: Pierre Fabre Ltd

• Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne.Active, not recruitingNCT07341659Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)CompletedNCT06690489

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma PatientsCompletedNCT04911998

  Sponsor listed in the registry: Pierre Fabre Medicament

• A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)CompletedNCT04317599

  Sponsor listed in the registry: Pierre Fabre Medicament

• The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up StudyTerminatedNCT06688370

  Sponsor listed in the registry: Pierre Fabre Medicament

• Evaluation of the Moisturizing Effect of Study Product AV0018B and the Persistence of This Effect After Repeated Applications, Compared to an Untreated Control Area.CompletedNCT07271628

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study.CompletedNCT06997718Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With NeratinibCompletedNCT05599334

  Sponsor listed in the registry: Pierre Fabre Medicament

• In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365CompletedNCT07208227

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis SkinCompletedNCT07194421

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic DermatitisCompletedNCT07194408

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory StudyCompletedNCT07166497

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus PlaceboCompletedNCT06763939

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic HyperplasiaCompletedNCT07144709

  Sponsor listed in the registry: Pierre Fabre Medicament

• Real-life Pan-HER-blockade With NeratinibCompletedNCT04388384

  Sponsor listed in the registry: Pierre Fabre Pharma GmbH

• A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)CompletedNCT05546905

  Sponsor listed in the registry: Pierre Fabre Medicament

• Exploratory Study to Evaluate the Efficacy of the Cosmetic Product RV3895A on Re-epidermised Scars Following Burns and Surgical Stitches in Adults, Adolescents and Children Over a 6-month Follow-up PeriodTerminatedNCT07020507

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic DermatitisCompletedNCT07017348Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re EpidermizationCompletedNCT06942403Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With ErythrocouperosisTerminatedNCT06824870Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Efficacy of Cosmetic Product RV3278B-OS0386 on Skin Surface Ecosystem, in Teenagers with Mild to Moderate Facial AcneCompletedNCT06659861Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique

• Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic AlopeciaTerminatedNCT06854432Not applicable

  Sponsor listed in the registry: Pierre Fabre Dermo Cosmetique